National Peroxide Swings to ₹11 Cr Profit in FY26, Plans ₹7 Dividend

CHEMICALS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
National Peroxide Swings to ₹11 Cr Profit in FY26, Plans ₹7 Dividend
Overview

National Peroxide Ltd reported a significant turnaround in its audited FY26 results, posting a Profit After Tax of ₹11.04 crore against a loss of ₹2.25 crore in FY25. Revenue from operations increased marginally to ₹289.71 crore. The board recommended a final dividend of ₹7 per share and approved key managerial appointments, including a new CFO and CRO from June 1, 2026.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

National Peroxide Reports ₹11 Crore Profit in FY26, Recommends ₹7 Dividend

National Peroxide has reported a significant turnaround in its audited financial results for the fiscal year ended March 31, 2026. The company posted a Profit After Tax (PAT) of ₹11.04 crore, a notable shift from the ₹2.25 crore loss in the previous year. Revenue from operations increased slightly to ₹289.71 crore from ₹286.87 crore.

The board has recommended a final dividend of ₹7 per equity share. Alongside these financial results, which received a clean audit report, the company also approved key managerial appointments and proposed a ₹17 lakh commission for Non-Executive Directors, pending shareholder approval at the upcoming Annual General Meeting (AGM).

This return to profitability is a crucial indicator of operational recovery for National Peroxide, a part of the Wadia Group and a key player in India's hydrogen peroxide market. The company had reported losses in FY24 (₹1.75 crore) and FY25 (₹2.25 crore), making the FY26 profit a significant turnaround.

The recommended dividend provides a direct return to shareholders, while the approved executive changes are aimed at strengthening financial governance and risk oversight. The new appointments, effective June 1, 2026, include Mr. Chirag Kothari as Chief Financial Officer (CFO) and Chief Risk Officer (CRO), bringing over 20 years of experience to the roles.

National Peroxide operates in the hydrogen peroxide market, a niche segment within the broader chemicals industry. Direct listed peers focused solely on hydrogen peroxide are limited in India. Companies like Gujarat Alkalies and Chemicals Ltd and GHCL Ltd are broader chemical players, and their performance may not be directly comparable due to diversified business lines.

Key points for shareholders to watch include the approval of the final dividend and the proposed director commission at the upcoming AGM. The successful transition of leadership under Mr. Kothari will also be important. Investors will be monitoring future revenue growth and margin expansion as indicators of sustained performance.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.